drugset / Trial / NCT00803855

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD1446 to Healthy Volunteers

NCT00803855

Phase 1 Completed 110 enrolled AstraZeneca
RandomizedSingle-groupDouble-blindBasic science

Summary

The primary purpose of this study is to assess the safety and tolerability of AZD1446 following single dose administration.

Timeline

Start
2008-12
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1446 Small molecule Oral

Indications

No indication recorded.